Skip to main content

Maria Nazarena Pizzi

Institutions of which they are part

Senior researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Maria Nazarena Pizzi

Institutions of which they are part

Senior researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Insulin resistance in type 2 diabetes: unraveling the pathogenic mechanism between organs

IP: José Raul Herance Camacho
Collaborators: Fiorella Dellepiane Clarke, Joan Castell Conesa, Insulin resistance in type 2 diabetes: unraveling the pathogenic mechanism between organs, Insulin resistance in type 2 diabetes: unraveling the pathogenic mechanism between organs, Nuria Roson Gradaille, Carolina Aparicio Gomez, Alberto Roque Pérez, Mònica Velasco Nuño, Julia Baguña Torres, Irene Hernández Hernández, Maria Nazarena Pizzi
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI20/01588
Duration: 01/01/2021 - 30/06/2025

Grups de recerca en Imatge Mèdica Molecular

IP: José Raul Herance Camacho
Collaborators: Joan Castell Conesa, Amparo García Burillo, Manuel Escobar Amores, Gemma Cuberas Borros, Grups de recerca en Imatge Mèdica Molecular, Roso Marès Pagès, Marc Simo Perdigo, Carles Lorenzo Bosquet, Maria Nazarena Pizzi
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 10000
Reference: 2017SGR1303
Duration: 01/01/2017 - 30/09/2021

Resistencia insulínica en miocardio como factor de riesgo cardiovascular en Diabetes Mellitus tipo 2

IP: José Raul Herance Camacho
Collaborators: Gemma Cuberas Borros, Resistencia insulínica en miocardio como factor de riesgo cardiovascular en Diabetes Mellitus tipo 2, Julia Baguña Torres, Maria Nazarena Pizzi
Funding agency: Instituto de Salud Carlos III
Funding: 128865
Reference: PI16/02064
Duration: 01/01/2017 - 30/06/2021

Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary clinical and experimental approach

IP: -
Collaborators: Ignacio Ferreira González, José Antonio Barrabés Riu, Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary c, Joan Montaner Villalonga, Immaculada Raurell Saborit, Joan López Hellin, Antonio González Fernández, Antonia Sambola Ayala, Marta García Ramírez, Joaquin Lopez Soriano, Anna Meseguer Navarro, Antonio Rodríguez Sinovas, Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary c, Rafael Simó Canonge, Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary c, Francesc Moreso Mateos, Cristina Hernández Pascual, Anna Penalba Morenilla, Maria Nieves Martell Pérez-Alcalde, Neus Bellera Gotarda, Natalia Ramos Terrades, Andreea Ciudin Mihai, Maria Mar Hernandez Guillamon, Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary c, Meritxell Ibernon Vilaró, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno García del Blanco, Daniel Serón Micas, María Eugenia Espinel Garuz, Marisol Ruiz Meana, Maria Pilar Delgado Martínez, Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary c, Irina Betsabe Torres Rodriguez, Javier Inserte Igual, Anna Rosell Novel, Olga Simó Servat, Joan Genescà Ferrer, Mònica Pons Delgado, M Antonieta Azancot Rivero, Maria Nazarena Pizzi, M Antonieta Azancot Rivero
Funding agency: Instituto de Salud Carlos III
Funding: 825000
Reference: PIE13/00027
Duration: 01/01/2014 - 30/06/2018

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

José vicente Andres Peiro

José vicente Andres Peiro

Reconstructive Surgery of the Locomotor System
Read more
Franco Marinello

Franco Marinello

Senior researcher
General Surgery
Read more
Maria Martinez Martinez

Maria Martinez Martinez

Main researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Leire Sanchez Corujo

Leire Sanchez Corujo

Predoctoral researcher
General Surgery
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.